Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCG-2671 in Healthy Participants and Participants with Obesity
NCT07815678Phase 2Recruiting
- Sponsor
- Structure Therapeutics
- Start
- Dec 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 2 trial of ACCG-2671 in obesity, sponsored by Structure Therapeutics. Started Dec 2025; status: recruiting.
02
Drugs
ACCG-2671
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07815678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07815678.